Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas-Reference-Cited by-同舟云学术

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas

Published:2022-04 Issue: Volume:40 Page:100980
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Crowley Fionnuala,Cadoo Karen A.,Chiang Sarah,Mandelker Diana L.,Bajwa Raazi,Iasonos Alexia,Zhou Qin C.,Miller Kathryn M.,Hensley Martee L.,O'Cearbhaill Roisin E.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference22 articles.

1. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population;Abeler;Histopathology,2009

2. Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature;Altman;Int. J. Gynecol. Cancer,2012

3. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Endometrial Stromal Sarcoma;Amant;Int. J. Gynecologic Cancer.,2014

4. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?;Barney;Int. J. Gynecol. Cancer.,2009

5. Low-grade endometrial stromal sarcoma: hormonal aspects;Chu;Gynecol. Oncol.,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study);International Journal of Gynecologic Cancer;2024-05-09